Their recommendations and resultant decision trees are summarized in Table 2 and Figure 2
In terms of specifics, the main finding was that about 28% of patients on ixekizumab alone achieved PASI-100 [a 100% improvement in Psoriasis Area Severity Index score], or complete clearance, and about 40% of patients on the combined drugs achieved complete clearance at the primary end point
Support for the study was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK139324, R01 DK115534, K01 DK138273)
Glutathione synthetase and glutathione synthetase deficiency are shown in the upper left of the figure
The adaptive immune system
The inhibition of protein kinase C (PKC), NADPH oxidase, and NF-B signaling exhibited anti-oxidative and anti-inflammatory effects in endothelial cells, accompanied by the upregulation of protective anti-oxidative enzymes [57]